Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study Amishi Y. Shah*, Jose A. Karam*, Gabriel G. Malouf†, Priya Rao*, Zita D. Lim*, Eric Jonasch*, Lianchun Xiao*, Jianjun Gao*, Ulka N. Vaishampayan‡, Daniel Y. Heng§, Elizabeth R. Plimack¶, Elizabeth A. Guancial**, Chunkit Fung**, Stefanie R. Lowas ††, Pheroze Tamboli*, Kanishka Sircar*, Surena F. Matin*, W. […]
From Williams et al, BJUI 2016
Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the […]
Contemporary recommendations for prostate screening incorporate the measurement of serum PSA levels into shared decision making [1]. PSA is limited by a low specificity for prostate cancer and exposes a certain number of men to unnecessary prostate biopsies. Moreover, it has been attributed to an over-diagnosis and over treatment of this disease, especially in indolent cancer […]
Images from Rundstedt et al, BJUI 2017
Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the […]
This issue’s Article of the Month is the NICE Bladder Cancer Guidance The cover features Admiralty Arch, a landmark building in London, adjacent the NICE office, which incorporates an archway providing road and pedestrian access between The Mall and Trafalgar Square. Image © Scott Millar 2017 Click here for this issue’s Table of Contents
Every month the Editor-in-Chief selects an Article of the Month from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full article, which is freely available to all readers for at least 30 days from the time of this post. In addition to the […]
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer Abstract Objective To assess the feasibility and safety of stereotactic ablative body radiotherapy (SABR) for renal cell carcinoma (RCC) in patients unsuitable for surgery. Secondary objectives were to assess oncological and functional outcomes. Materials and Methods This was a prospective interventional clinical trial with institutional ethics […]